Cellular and Molecular Neurobiology

, Volume 15, Issue 3, pp 361–370

Chronic administration of the antidepressants phenelzine, despiramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain

Authors

  • Kathryn G. Todd
    • Neurochemical Research Unit, Department of Psychiatry, and Faculty of Pharmaceutical SciencesUniversity of Alberta, Edmonton
  • David J. McManus
    • Neurochemical Research Unit, Department of Psychiatry, and Faculty of Pharmaceutical SciencesUniversity of Alberta, Edmonton
  • Glen B. Baker
    • Neurochemical Research Unit, Department of Psychiatry, and Faculty of Pharmaceutical SciencesUniversity of Alberta, Edmonton
Article

DOI: 10.1007/BF02089946

Cite this article as:
Todd, K.G., McManus, D.J. & Baker, G.B. Cell Mol Neurobiol (1995) 15: 361. doi:10.1007/BF02089946
  • 70 Views

Summary

1. The effects of chronic administration of five antidepressant drugs on the benzodiazepine and 5-HT2A binding sites in the same rat brain were assessed.

2. Clomipramine, desipramine, maprotiline, fluoxetine, and phenelzine (all 10 mg/kg/day) were administered s.c. for 21 days by Alzet osmotic minipumps.

3. Results showed that none of the drugs changed the density or affinity of benzodiazepine binding sites, yet at the same dose all the drugs with the exception of fluoxetine decreased binding to 5-HT2A receptors in the same animals.

Key words

antidepressantsbenzodiazepine receptorsclomipraminedesipraminefluoxetine5-hydroxytryptamine receptorsmaprotilinephenelzine
Download to read the full article text

Copyright information

© Plenum Publishing Corporation 1995